About
About

Immunic Therapeuctics
Immunic, Inc. is headquartered in New York City…
Immunic, Inc. is headquartered in New York City. Its subsidiary, Immunic AG, is based in Gräfelfing near Munich, Germany, where the company’s research and development activities are conducted.
Immunic AG was founded in 2016 with...
Immunic AG was founded in 2016 with headquarters in Planegg-Martinsried, Germany. Since April 2019, the company has been operating under the name Immunic, Inc. with its registered office in the United States and has been trading on the Nasdaq Stock Market under the ticker symbol ”IMUX.”
Management
Dr. Daniel Vitt
Chief Executive Officer, President and Director
Dr. Hella Kohlhof
Chief Scientific Officer
Dr. Andreas Muehler
Chief Medical Officer
Patrick Walsh
Chief Business Officer
Glenn Whaley, CPA
Chief Financial Officer
Inderpal Singh
General Counsel
Dr. Duane Nash
Executive Chairman
Board of Directors
Dr. Duane Nash
Executive Chairman
Dr. Daniel Vitt
Chief Executive Officer, President and Director
Barclay “Buck” Phillips
Lead Independent Director
Tamar Howson
Independent Director
Dr. Jörg Neermann
Independent Director
Dr. Richard Rudick
Independent Director
Maria Törnsén
Independent Director
Scientific-Medical Advisory Board
Fred D. Lublin, M.D.
Icahn School of Medicine at Mount Sinai
Bruce E. Sands, M.D., M.S
Icahn School of Medicine at Mount Sinai
Paul J. Utz, M.D.
Stanford University School of Medicine